Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
High-throughput, quantitative approach to peptide epitope discovery.
Journal: Medical & biological engineering & computing
Published: December 03, 2025
Chemical Complementarities of Neuroblastoma Tumor-Resident TCR CDR3s and CMV Antigens are Associated with a Better Outcome.
Journal: Biochemical genetics
Published: November 17, 2025
Higher chemical complementarity of EBV epitopes and IGH CDR3s correlates with better outcomes for lymphoma and ovarian cancer.
Journal: Cancer causes & control : CCC
Published: July 10, 2025
A quantitative assessment of TRB CDR3-CMV antigen chemical interactions distinguishes schizophrenia patients in case/control comparisons.
Journal: Psychiatry research
Published: June 17, 2025
TCR CDR3 chemical complementarity to HPV epitopes is associated with a better outcome for cervical cancer.
Journal: Mammalian genome : official journal of the International Mammalian Genome Society
Published: January 14, 2025
Detection of Anti-CMV TCR CDR3s via Blood and Tumor Exome Files Correlates With Increased Survival for Stomach Adenocarcinoma and Soft Tissue Sarcoma.
Journal: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
Published: January 02, 2025
Better Outcomes for Ovarian Cancer Associated With the Detection of Anti-EBV TCR CDR3s: Potential Relevance to Diffuse Large B-Cell Lymphoma.
Journal: American journal of reproductive immunology (New York, N.Y. : 1989)
Published: July 29, 2024
A computational approach to matching multiple sclerosis-related, IGH CDR3s with a MBP epitope.
Journal: Computers in biology and medicine
Published: July 20, 2024
Detection of anti-EBV TCR CDR3s associated with better outcomes for EBV-positive, Ugandan cases of Burkitt lymphoma.
Journal: International journal of cancer
Published: June 25, 2024
Chemical Complementarity of Blood-Sourced, Breast Cancer-Related TCR CDR3s and the CMV UL29 and IE1 Antigens is Associated with Worse Overall Survival.
Journal: Biochemical genetics
Published: June 18, 2024
IGH Complementarity Determining Region-3-Cytomegalovirus Protein Chemical Complementarity Linked to Better Overall Survival Probabilities for Glioblastoma.
Journal: Viral immunology
Published: June 07, 2024
Worse Wilms' Tumor Outcomes Associated With Chemical Complementarity for Multiple T-Cell Receptor CDR3-CMV Epitope Pairs.
Journal: Cancer genomics & proteomics
Published: May 28, 2024
Last Updated: 09/26/2026